Psychotherapy Works for Eating Disorders, But Not for Everyone, Massive Trial Analysis Finds

For decades, cognitive behavioral therapy has been prescribed as the gold-standard treatment for eating disorders, the approach that clinical guidelines place at the top of the treatment hierarchy for bulimia nervosa, binge-eating disorder, and related conditions. Yet clinicians and researchers have long known an uncomfortable truth: a substantial share of patients who complete CBT do not fully recover, and several other forms of psychotherapy appear to help many of the same people. A sweeping new meta-analysis published in the Journal of Eating Disorders has now brought those competing threads together in the most comprehensive controlled comparison to date, and its findings are both encouraging and sobering in equal measure.

The study, led by Elena Koning of Dalhousie University and Nova Scotia Health together with colleagues from institutions including Vrije Universiteit Amsterdam and Deakin University, pooled data from 47 randomized controlled trials encompassing 57 treatment comparisons and 3,018 adults. Unlike earlier syntheses that focused narrowly on CBT, the team deliberately widened the aperture to include non-CBT guided psychotherapies such as dialectical behavioral therapy, interpersonal psychotherapy, and emotion-focused therapy. The goal was to determine, for the first time, the controlled effect of psychotherapy as a class against comparison conditions, which were primarily waitlist controls or care-as-usual arrangements.

The headline result is striking. Across all eating disorder diagnoses combined, psychotherapy produced a large overall effect on eating disorder psychopathology, with a standardized effect size of Hedges’ g equal to 0.96 and a 95 percent confidence interval running from 0.79 to 1.14. In practical terms, an effect of this magnitude means the average treated patient fared better than roughly 83 percent of untreated or usual-care controls, a difference that places eating disorder psychotherapy among the more effective interventions in all of mental health care. The effects were remarkably consistent across diagnostic categories, with bulimia nervosa showing an effect size of 0.97 and binge-eating disorder an almost identical 0.95.

Perhaps the most consequential finding for the field is what the analysis did not find: any significant difference between CBT and its non-CBT rivals. Dialectical behavioral therapy, interpersonal psychotherapy, emotion-focused therapy, and other guided approaches performed on par with the presumed gold standard. This challenges a long-standing assumption embedded in treatment guidelines and insurance policies around the world, namely that CBT should be the default first-line option while other therapies serve as fallbacks. The authors suggest that the common therapeutic ingredients shared across these modalities, rather than any single theoretical framework, may be driving much of the benefit.

The binary outcome data tell the story in raw clinical terms. After treatment, 37 percent of patients receiving psychotherapy had achieved abstinence from binge eating, compared with just 18 percent of those in control conditions, yielding a relative risk of 3.79 with a confidence interval of 2.98 to 4.83. In other words, treated adults were nearly four times as likely to stop binge eating as their untreated counterparts. Secondary outcomes reinforced the pattern, with statistically significant effects on binge eating frequency, vomiting episodes, and concerns about shape, weight, and eating, the core cognitive symptoms that maintain these disorders and predict relapse.

Methodologically, the analysis was conducted with considerable statistical sophistication. The researchers used Hedges’ g for continuous outcomes and relative risks for binary outcomes, and they ran their models with the metapsyTools R package, an open-source platform designed for handling the correlated and hierarchical structure of multi-arm psychotherapy trials. This matters because psychotherapy trials frequently include multiple treatment arms and multiple outcome measures per study, and naive pooling can distort effect estimates. By modeling these dependencies explicitly, the team reduced the risk of overstating both the size and the precision of their findings.

But the analysis also delivered a cautionary note that the authors do not shy away from. When the team examined the subset of studies judged to have a low risk of bias, the effects were attenuated, meaning the most methodologically rigorous trials produced smaller benefits than the literature as a whole. This is a familiar pattern in psychotherapy research, where blinding is difficult, expectation effects are powerful, and waitlist comparisons can inflate apparent treatment effects. The finding does not overturn the conclusion that psychotherapy works, but it tempers the enthusiasm and suggests the true effect likely sits somewhere below the headline estimate.

Even more sobering is the recovery gap that persists despite the large average effects. If only 37 percent of treated patients achieve binge-eating abstinence against 18 percent of controls, then roughly two-thirds of adults receiving first-line psychotherapy do not reach that benchmark of clinical remission. The authors are explicit on this point: psychotherapy should remain the first-line treatment for eating disorders, but there remains a pressing need for improved therapeutic approaches. The number needed to treat implied by these figures, while respectable by mental health standards, underscores that current therapies are a starting point rather than a solution.

The implications ripple outward in several directions. For clinicians, the equivalence finding means that patient preference, therapist training, and practical considerations such as format and duration can legitimately guide the choice among evidence-based psychotherapies, rather than a rigid CBT-first mandate. For guideline developers, the results argue for broadening first-line recommendations to include non-CBT modalities supported by randomized trial evidence. For researchers, the persistent remission gap and the risk-of-bias attenuation together define the field’s next frontier: developing interventions that work for the many patients whom current approaches leave behind, and designing trials rigorous enough to measure honestly whether they do.

Published open access and citable under a permanent DOI, the analysis arrives at a moment when eating disorders are receiving unprecedented public attention and demand for treatment continues to outpace service capacity. Its message to patients and families is genuinely hopeful: guided psychotherapy, in several distinct forms, produces large and measurable reductions in the symptoms that make these illnesses so destructive. Its message to the research community is equally clear. The era of asking whether psychotherapy works for eating disorders in adults is essentially over; the era of asking how to make it work for everyone has begun.

Subject of Research: Controlled effects of CBT and non-CBT psychotherapy for eating disorders in adults

Article Title: The effects of eating disorder psychotherapy in adults: a meta-analysis of randomized controlled trials

Article References: Koning, E., Trappenberg, N., Harris, A., Brown, V., Mittertreiner, E. J., Sheppard, S., Sprenger, A. A., Harrer, M., Cuijpers, P., Linardon, J., & Keshen, A. (2026). The effects of eating disorder psychotherapy in adults: a meta-analysis of randomized controlled trials. Journal of Eating Disorders. https://doi.org/10.1186/s40337-026-01794-5

Image Credits: AI Generated

DOI: 10.1186/s40337-026-01794-5

Keywords: eating disorders, psychotherapy, cognitive behavioral therapy, meta-analysis, bulimia nervosa, binge-eating disorder, dialectical behavioral therapy, interpersonal psychotherapy, randomized controlled trials, remission rates, mental health, clinical psychology